MSN 675 MODULE 4 QUIZ QUESTIONS ANSWERED CORRECTLY LATEST UPDATE 2026

MSN 675 MODULE 4 QUIZ QUESTIONS ANSWERED CORRECTLY LATEST UPDATE 2026 Positive symptoms of psychotic disorders - Answers Hallucinations, delusions, and disorganized behavior. Negative symptoms of psychotic disorders - Answers Alogia, affective flattening, avolition, and anhedonia. Cognitive symptoms of psychotic disorders - Answers Decreased concentration, disorganized thinking, and poor memory. RTIS - Answers Responding to internal stimuli. Signs of Responding to Internal Stimuli (RTIS) - Answers Eyes looking around, whispering, giggling, or engaging with things not there. Schizophrenia: Active symptom requirement - Answers At least two symptoms lasting for a full month. Schizophrenia: Core symptom requirement - Answers At least one must be delusions, hallucinations, or disorganized speech. Schizophrenia: Total duration requirement - Answers Prodromal and residual symptoms present for at least six months. Schizophrenia: Typical age of onset - Answers Early twenties (rare in children). Schizophrenia: Risk factor evaluation - Answers Family history, due to a strong genetic link. Schizotypal personality disorder: Key feature - Answers Mild symptoms that almost seem like personality quirks. Delusional disorder: Key feature - Answers Symptoms are usually limited only to delusions. Brief psychotic disorder: Duration - Answers Psychotic symptoms last from one day to a month. Schizoaffective disorder: Key distinction - Answers Mood episodes occur before or after psychotic symptoms and overshadow the presentation. Schizophreniform disorder: Key features - Answers Less apparent mood episodes; symptoms last between one and six months. Substance/medication-induced psychotic disorder: Diagnosis basis - Answers Relies on a history of medication or substance use. Psychotic disorder induced by another medical condition: Requirement - Answers Proof that a physical disease is causing the psychotic symptoms. Other specified and unspecified schizophrenia spectrum disorders: Use - Answers Reserved for symptoms that do not fit criteria for other conditions. Psychotic disorders: Typical pharmacological treatment - Answers Second-generation antipsychotics like Risperdal, Invega, Seroquel, Abilify, Zyprexa, Geodon, or Latuda. Treatment-resistant schizophrenia: Medication of choice - Answers Clozapine. Clozapine: Monitoring requirement and risk - Answers Requires registry enrollment and close monitoring due to risk of agranulocytosis. Psychotic disorders: Adjunctive therapies - Answers Social approaches, Cognitive Behavioral Therapy (CBT), and Electroconvulsive Therapy (ECT). SGA prescription: EPS assessment - Answers Assess for unusual muscle movements, tightness, pain, cogwheeling, or stiffness. Oculogyric crisis - Answers An EPS where eyes roll back and shake, resembling seizure activity. Cogentin for EPS: Caution - Answers Avoid indefinite scheduling due to risks of sedation and cognitive dulling. Personality disorder diagnosis constraint - Answers Do not diagnose personality disorders while a patient is psychotic. First step in evaluating psychosis - Answers Rule out substance-induced psychosis before considering other diagnoses. Purpose of brain imaging in quick-onset psychosis - Answers To rule out physical causes for the symptoms. Barrier to diagnostic brain imaging in psychosis - Answers High cost and insurance coverage questions. Reason for diagnosing schizophreniform over schizophrenia - Answers Uncertainty if the patient will recover within a six-month period. Schizophrenia: Most common comorbid psychiatric condition - Answers Substance use. Substance-induced psychotic disorder: Support recommendation - Answers Referral to Alcoholics Anonymous (AA) and Narcotics Anonymous (NA). First-line treatment for catatonia - Answers Benzodiazepines (usually lorazepam) or electroconvulsive therapy (ECT). Reason to avoid antipsychotics in catatonia - Answers They may precipitate or worsen catatonia. Catatonia: Key approach for safety and compliance - Answers Establishing consistency and mutual trust. Antipsychotics: Treatment of negative symptoms - Answers Typicals are ineffective; atypicals may treat them through 5HT2A action. Medication adherence in psychosis: Key clinical approach - Answers Develop a comprehensive treatment plan that addresses potential barriers. Prior authorization: Benefits for adherence - Answers Identifies covered meds, guides side-effect education, and prompts monthly IM options. Long-acting injectables (LAIs): Best candidates - Answers Patients with a history of running away or irregular medication adherence. Psychosis treatment: Education target - Answers Provide extensive education to both the patient and their family. Zyprexa: Key clinical precaution - Answers Reconsider starting with it due to having the highest rate of weight gain. Antipsychotic side effects: Impact on adherence - Answers Severe side effects are often the primary reason patients stop taking their medication. Seroquel: Indication based on sedation - Answers Extremely anxious patients who have trouble sleeping. Seroquel and Trazodone: Combined risk - Answers Increases QTC interval; avoid in cardiac complications. Geodon and Abilify: Weight profile - Answers Tend to be more weight neutral. Geodon: Pre-treatment requirement - Answers Baseline ECG due to risk of increased QTC interval. Risperdal: FDA approval for children - Answers Approved for aggression in children. Risperdal: Side effect requiring consent discussion - Answers Gynecomastia, which is reversible by stopping the medication. Abilify: Indication for fatigued patients - Answers Activating effect for patients who are always tired. Abilify: Key side effect to monitor - Answers Akathisia. Antipsychotics: Periodic metabolic monitoring - Answers Cholesterol, weight, and glucose. Caregivers of schizophrenia patients: Recommended environment - Answers Support groups, to help prevent burnout from emotionally taxing care. Caregivers of schizophrenia patients: Common risk - Answers Burnout, due to the emotionally taxing nature of care. Schizophrenia: Role of a patient's support system - Answers Assisting with appointments, medications, nutrition, sleep, and activity monitoring. Schizophrenia vs. healthy individuals: Age-related brain structure change - Answers More pronounced brain volume reductions with age. What three tests should be checked at baseline and at 12 weeks after initiating an atypical antipsychotic? - Answers Weight (BMI), Fasting Blood Glucose (BG), and Fasting Lipids After the initial 12-week check, how frequently should weight (BMI) be monitored during follow-up? - Answers Every 16 weeks How frequently should fasting blood glucose (BG) and fasting lipids be monitored during long-term follow-up? - Answers Every year According to the chart, what three clinical management criteria signal metabolic worsening (triggering a "YES" on the flowchart)? - Answers ≥ 5% weight gain from baseline, Worsening / Hyperglycemia, and Worsening Dyslipidemia What are the recommended management options if a patient shows signs of metabolic worsening (a "YES" on the flowchart)? - Answers Consult the ordering prescriber or consider switching to an SGA with decreased metabolic disturbances What action should be taken if a patient does not show signs of metabolic worsening (a "NO" on the flowchart)? - Answers Continue current therapy According to the provided risk gradient, which two atypical antipsychotics carry the greatest risk of metabolic disturbances? - Answers Olanzapine and Clozapine According to the provided risk gradient, which two atypical antipsychotics carry the least risk of metabolic disturbances? - Answers Aripiprazole and Ziprasidone